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Applicability to Clinical 
Practice
Obesity rates have grown exponentially in the last few decades. 
In the United States obesity affects 12.5 million children.
Obesity increases the risk of hypertension, hyperlipidemia, 
diabetes, and sleep apnea.
On average in 2006 an obese person spent 42% more on health 
care than a normal weight person.
Overuse of antibiotics leading to alterations in gut microbiota 
has become one theory behind childhood obesity.
 In 2011 there were over 1,000 prescriptions for antibiotics per 
1,000 individuals ages birth to nine and ages older than sixty-
five. This means these groups are getting more than one 
antibiotic course per year
Obesity is becoming a growing concern in today’s population.  
Over the last thirty years, obesity rates have doubled in adults and 
quadrupled in adolescents.  One of the more recent theories is that 
childhood obesity is influenced by early exposure to antibiotics.  
The purpose of this project is to discuss how antibiotics alter the 
human gut microbiota and how this affects nutrient consumption, 
which can lead to childhood obesity.  There is a focus on the 
current research studies that address if, indeed, there is a link 
between childhood obesity and early antibiotic exposure. Through 
a review of several electronic databases and several peer reviewed 
research articles, my research has found that there is a link 
between early life antibiotic exposure and childhood obesity. 
Studies have shown that the younger the child is at the time of 
antibiotic exposure, the higher the risk of obesity. In addition, the 
more frequent the antibiotic exposure the higher the risk, and 
overall, males have a higher risk than females. These findings 
could have an impact on future clinical practice and probiotic use. 
Is antibiotic exposure in early childhood associated with an 
increased risk of obesity in later childhood and adolescence? 
Does the timing, frequency of antibiotic exposure, the 
pharmaceutical class of antibiotic, or the individual’s gender 
make a difference in weight gain?
Background of the Human Gut 
Microbiota 
The gut microbiota functions to help extract energy from foods, 
protect against colonization with harmful pathogens and 
microorganisms, and regulate proliferation and differentiation of 
epithelial cells. (Villanueva-Millian et al., 2015) Alterations in any 
of these can lead to dysbiosis. “Dysbiosis is an abnormal 
colonization or imbalance of microbes inhabiting a certain part of 
the body” (Houghteling & Walker, 2015).  Antibiotics alter the gut 
microbiota and increase the risk of obesity due to lasting effects 
on the immunity and metabolism capabilities of the gut. 
(Houghteling & Walker, 2015)
Current research shows that the gut microbiota is very important 
in the maintenance of health and weight.  The research has also 
shown that antibiotics affect the gut microbiota and probiotics 
help to maintain it.  If we are able to gain enough research into 
which types of probiotics give the most benefit and for what 
populations we could have improved outcomes in the future. 
Clinical trials of a medication called Vivomixx are in their 
beginning phases. This medication is a combination of 
Streptococcus thermophiles, bifidobacteria, and lactobacilli. 
This medication will be given to pregnant women starting 
between 14 and 20 weeks and continuing until delivery.  
Researchers hope to find that it can control weight gain, reduce 
pregnancy complications, and alter infant’s gut microbiota 
therefore promoting development and health (Halkjaer et al., 
2016). This new treatment modality could be very beneficial in 
clinical practice for attacking the obesity epidemic.
With the recent increase in adult and childhood obesity and the 
often inappropriate prescribing practices of antibiotics, we need to 
establish (1) Is there a causal link between antibiotic exposure and 
childhood obesity, and (2) What potential treatment modalities 
exist to prevent disturbances of gut microbiota when antibiotic 
treatment is necessary? 
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 Two studies have shown increased risk of obesity in children 
whose mothers were exposed to antibiotics during pregnancy.
One study showed an increased risk in obesity if the exposed 
mother is of normal weight but showed a decrease in obesity if 
the exposed mother was obese. One study did not show any 
relationship to obesity and exposure to antibiotics in utero but 
did show an increase if child is exposed in the first year.
 Eight studies have shown that there is an increase in childhood 
obesity when children are exposed to antibiotics in the first year 
of life. More often than not the studies showed this was 
especially true in males and with repeated antibiotic exposure. 
Author Sample Findings Downfalls
Muller et al., 2015 436 women/children 
pairs
84% increased risk of obesity when exposed to antibiotics in the second or third 
trimester
Population was narrowed to African 
American and Dominican Women. Could 
not generalize to entire population
Ajslev et al., 2011 28,354 
women/children pairs
Antibiotics given to normal weight mothers increased risk of children being 
overweight (OR 1.54, 95% CI: 1.09-2.17).
Antibiotics given to obese mothers children had a decreased risk of becoming 
overweight (OR: 1.05, 95% CI: 0.58-1.89)
Height and weight were self-reported
Trasande et al., 2012 11,532 children Children of normal weight exposed to antibiotics at less than six months of age had a 
29.4% increase in being overweight at 38 months.  
Saari et al., 2015 6,114 boys and 5,948 
girls
In males any exposure and the younger the child at time of exposure the greater the 
impact on increased BMI. Largest difference was when boys were exposed to 
macrolides two or more times. 
Bailey et al., 2014 64,580 children Four or more broad spectrum courses of antibiotics increased obesity risk p=0.02
Scott et al., 2016 21,714 children Children exposed to antibiotics in the first two years of life especially repeating 
doses of antibiotics there was a 25% relative increase for risk of childhood obesity.
Murphy et al., 2014 74,946 children Increased risk of obesity with early antibiotic exposure in boys p<0.0007 but was 
not statistically significant in girls p=0.34
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Potential Treatment Modalities 
Probiotics have been used to maintain gut microbiota and are 
currently being suggested as a potential treatment for obesity. At 
this time there has been limited research on this topic especially in 
regard to children.  However, a series of studies by Kadooka et al. 
(2010) has shown that consumption of Lactobacillus gasseri 
(LB2055) at concentrations of 106 cfu have shown reduction in 
visceral fat, BMI, and hip and waist circumference.  This study 
does show that continuous supplementation is needed to preserve 
this effect. 
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